Less Ads, More Data, More Tools Register for FREE

Pin to quick picks65WK.L Regulatory News (65WK)

  • There is currently no data for 65WK

Supplemental Prospectus

1 Nov 2021 07:00

RNS Number : 8061Q
Santander UK Group Holdings PLC
29 October 2021
 

SANTANDER UK GROUP HOLDINGS PLCSANTANDER UK PLC€30,000,000,000 EURO MEDIUM TERM NOTE PROGRAMMEPUBLICATION OF SUPPLEMENTARY PROSPECTUS

 

The following supplementary prospectus (the Supplementary Prospectus) has been approved by the UK Financial Conduct Authority and is available for viewing:

 

Supplementary Prospectus dated 27 October 2021 to the prospectus dated 12 May 2021, as supplemented on 28 July 2021 and 13 August 2021 relating to the €30,000,000,000 Euro Medium Term Note Programme of Santander UK Group Holdings plc and Santander UK plc (the Prospectus).

 

To view the full Supplementary Prospectus please paste the following URL into the address bar of your browser:

 

http://www.rns-pdf.londonstockexchange.com/rns/8061Q_1-2021-10-29.pdf

 

A copy of the Supplementary Prospectus has been submitted to the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

The Supplementary Prospectus will also be available for viewing via:

 

https://www.santander.co.uk/about-santander/investor-relations/euro-medium-term-note-programme

 

 

For further information, please contact:

 

Medium Term FundingSantander UK plc2 Triton SquareRegent's PlaceLondon NW1 3AN

Tel: +44 (0) 20 7756 7100

Email: mtf@santander.co.uk

 

DISCLAIMER - INTENDED ADDRESSEES

 

Please note that the information contained in the Supplementary Prospectus and the Base Prospectus may be addressed to and/or targeted at persons who are residents of particular countries only (as specified in the Base Prospectus) and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Base Prospectus is not addressed. Prior to relying on the information contained in the Base Prospectus you must ascertain from such Base Prospectus whether or not you are part of the intended addressees of the information contained therein.

 

This publication of the Supplementary Prospectus does not constitute an offer of securities for sale in the United States. The securities described in the Base Prospectus have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the Securities Act), or under any relevant securities laws of any state of the United States of America, and may not be offered or sold in the United States of America or to, or for the benefit of, U.S. persons (as defined in Regulation S of the Securities Act), unless the securities are registered under the Securities Act or an exemption from the registration requirements of the Securities Act is available.

 

Your right to access this service is conditional upon your compliance with the above requirement.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PSPFEIFWUEFSEES
12
Date   Source Headline
28th Apr 20217:00 amRNSQuarterly Management Statement - Q1 2021
16th Apr 20218:58 amRNSPART VII BANKING BUSINESS TRANSFER SCHEME
22nd Mar 20213:27 pmRNSSeries of Notes Pricing of Cash Tender Offers
22nd Mar 202112:49 pmRNSSeries Notes - Increase to Tender & Early Results
18th Mar 20215:30 pmRNSAGM Statement
8th Mar 20212:58 pmRNSTender Offer - Two series of Notes
3rd Mar 20211:21 pmRNSPublication of Supplementary Prospectus
2nd Mar 20216:22 pmRNSAnnual Financial Report
3rd Feb 20212:09 pmRNSPublication of Supplementary Prospectus
3rd Feb 20217:15 amRNSQ4 2020 - Quarterly Management Statement
18th Dec 20204:22 pmRNSDirectorate Change
18th Dec 20203:38 pmRNSNotice of Pricing Terms to Holders of Bonds
18th Dec 202011:41 amRNSNotice of Meeting Results - Holders of Bonds
15th Dec 20201:00 pmRNSExpiration and Results of Cash Tender Offers
1st Dec 20205:09 pmRNSPricing of Tender Offers for Four Series of Notes
1st Dec 20201:28 pmRNSEarly Results Tender Offers for Four Series Notes
26th Nov 202012:26 pmRNSNotice to Covered Bondholders
12th Nov 20204:58 pmRNSCash Tender Offers for Four Series of Notes
27th Oct 20205:45 pmRNSPublication of Supplementary Prospectus
27th Oct 20201:23 pmRNSPublication of Supplementary Prospectus
27th Oct 20207:15 amRNSQ3 2020 - Quarterly Management Statement
7th Sep 20201:59 pmRNSNotice of Early Redemption for Noteholders
14th Aug 20203:49 pmRNSNotice of Early Redemption - Fixed Rate Notes
11th Aug 20203:08 pmRNSPublication of Supplementary Prospectus
11th Aug 20202:59 pmRNSPublication of Supplementary Prospectus
11th Aug 20207:15 amRNSHalf-year Report
7th Aug 20207:00 amRNSBoard Changes at Santander UK
4th Aug 20204:59 pmRNSArticle 17
3rd Aug 20208:32 amRNS1172 ISE Delisting Announcement
29th Jul 202012:34 pmRNSPublication of Supplementary Prospectus
29th Jul 202012:09 pmRNSPublication of Supplementary Prospectus
29th Jul 20207:15 amRNSQuarterly Management Statement - 30 June 2020
21st Jul 20208:31 amRNSPOP Delisting
9th Jul 20203:42 pmRNSArticle 8
6th Jul 20207:37 amRNS1170 ISE Delisting Announcement
30th Jun 20205:03 pmRNSPublication of a Prospectus
16th Jun 20206:44 pmRNSPublication of a Prospectus
12th May 20208:20 amRNSNOTICE OF DELISTING
11th May 20203:26 pmRNSArticle 8
30th Apr 20202:02 pmRNSPublication of Supplementary Prospectus
30th Apr 20208:25 amRNSNotice of Delisting
28th Apr 20207:15 amRNS1st Quarter Results
16th Apr 202012:11 pmRNSGlobal Covered Bond Programme - Final Terms Amend
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.